Key Highlights

  • Solesence (NASDAQ:SLSN) was trading up 33.1% at USD 1.2099 on Friday, November 13, 2026, in market data, which implies a prior close near USD 0.91 (calculated); no company announcement explaining the move was found.
  • Second quarter 2026 Revenue was USD 15.3 million against USD 20.4 million a year earlier, according to published coverage of the company's report of August 19, 2026, a fall of about 25% (calculated).
  • Published market data listed trailing twelve month revenue of USD 55.37 million, down 14.0%, and a trailing net loss of USD 2.91 million as of October 23, 2026.
  • On October 23, 2026 the stock was USD 0.8005 with about 70.65 million shares outstanding, so the current quote implies a Market Value near USD 85 million (calculated), against USD 56.55 million then.

A 33.1% Move Without a Company Announcement

Solesence (NASDAQ:SLSN) was trading up 33.1% at USD 1.2099 on Friday, November 13, 2026, in market data. No company announcement explaining the move was found for November 11 to 13. A market data page had listed November 10, 2026 as the expected date of the next report, but no third-quarter 2026 results release was located, so it is unclear whether results are out. Solesence, formerly Nanophase Technologies, makes surface-engineered zinc oxide and titanium dioxide ingredients and mineral-based UV protection products. It is based in Romeoville, Illinois, and changed its name in March 2025. The shares have been volatile: a market data page showed a 6.54% fall on October 23, 2026 alone.

Second Quarter Revenue Fell as Launch Timing Slipped

The company reported second quarter 2026 results on August 19, 2026. Published coverage put revenue at USD 15.3 million against USD 20.4 million a year earlier, and a summary of the Earnings Call said the decline reflected product launch timing while gross Margin held steady. Another report described earnings as around break-even, with high operating costs weighing. Trailing twelve month revenue was USD 55.37 million, down 14.0%, and the trailing net loss was USD 2.91 million, as shown on a market data page updated October 23, 2026. No full-year guidance figures were found, so there is no company target to test the quote against.

Late Filing History, Valuation and Thin-Trade Risk

The company filed a notice of a late Quarterly Report on August 14, 2026 and filed the report on August 19. Its Annual Report followed on March 31, 2026, with an amendment on April 23. At USD 0.8005 on October 23 the market value was about USD 56.55 million on 70.65 million shares, so the quote of USD 1.2099 implies about USD 85 million (calculated). Risks include launch timing, ingredient Demand and thin trading: a small number of trades can move the price, spreads can be wide and quoted gains can reverse.

Where Things Stand

No verified cause explains the 33.1% rise. Solesence (NASDAQ:SLSN) is quoted at USD 1.2099 after trading near USD 0.80 on October 23, 2026, yet the most recent verified results show falling revenue and a small loss. The next marker is the third-quarter report and any announcement that explains the jump. Until then the move is best read as a quote on a small company with limited disclosure, not a confirmed change in fundamentals. The 33.1% is the figure of record for the live session only, and the screener's prior close can be thin for small stocks.